USA Financial Formulas’s Leidos LDOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,588
Closed -$647K 494
2025
Q4
$647K Buy
+3,588
New +$680K 0.12% 69
2024
Q4
Sell
-7,338
Closed -$1.2M 336
2024
Q3
$1.2M Sell
7,338
-362
-5% -$54.8K 0.19% 49
2024
Q2
$1.12M Sell
7,700
-2,188
-22% -$306K 0.18% 44
2024
Q1
$1.3M Buy
+9,888
New +$1.18M 0.21% 38
2021
Q1
Sell
-8
Closed -$1K 388
2020
Q4
$1K Hold
8
﹤0.01% 286
2020
Q3
$1K Hold
8
﹤0.01% 271
2020
Q2
$1K Sell
8
-18,952
-100% -$1.87M ﹤0.01% 178
2020
Q1
$1.74M Sell
18,960
-10,902
-37% -$1.1M 1.11% 31
2019
Q4
$2.92M Buy
29,862
+7,034
+31% +$620K 1.21% 23
2019
Q3
$1.96M Buy
+22,828
New +$1.91M 0.76% 66
2016
Q1
Sell
-4,748
Closed -$267K 97
2015
Q4
$267K Buy
+4,748
New +$250K 0.11% 85

Other funds holding LDOS

USA Financial Formulas's LDOS Position: Q1 2026 in Review

USA Financial Formulas sold out of Leidos (LDOS) in Q1 2026, closing a stake of 3,588 shares — an estimated $647K sold.

USA Financial Formulas first reported a position in LDOS in Q4 2015 and held it in 11 quarters. The position peaked at $2.92M in Q4 2019. 901 funds tracked by Wall St. Rank hold LDOS as of Q1 2026.

  • USA Financial Formulas reported no remaining Leidos position as of Q1 2026 after selling out during the quarter.
  • USA Financial Formulas sold 3,588 Leidos shares in Q1 2026, an estimated $647K.
  • USA Financial Formulas first reported a position in Leidos in Q4 2015 and held it in 11 quarters.
  • USA Financial Formulas's Leidos position peaked at $2.92M in Q4 2019.
  • 901 funds tracked by Wall St. Rank held Leidos as of Q1 2026.

Based on USA Financial Formulas's 13F filing for Q1 2026, filed 14 Apr 2026.